Clinical Trial Update: Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis [Phase 4]

View source ↗

Summary

Phase 4 trial update exploring icodextrin delaying the transition from low dose to full dose dialysis in the first year of incremental peritoneal dialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Dialysis-related Conditions

Drugs mentioned

• Icodextrin (icodextrin)

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: Peritoneal Dialysis | Phase 4 | Status: RECRUITING